Senator Hassan Presses Big Pharma Companies on Increasing Access to Lower-Cost Insulin
May 12, 2023
May 12, 2023
WASHINGTON, May 12 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release on May 10, 2023:
U.S. Senator Maggie Hassan today pressed three major insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi, on increasing access to lower-cost insulin for Americans with diabetes. Senator Hassan also questioned major pharmacy benefit managers, CVS Caremark and Express Scripts, on their role in these efforts.
Senator Hassan opened by recounting the all-too-c . . .
U.S. Senator Maggie Hassan today pressed three major insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi, on increasing access to lower-cost insulin for Americans with diabetes. Senator Hassan also questioned major pharmacy benefit managers, CVS Caremark and Express Scripts, on their role in these efforts.
Senator Hassan opened by recounting the all-too-c . . .